Nomenclature
CAS number: 133-65-3
1,1′-[Sulfonylbis(4,1-phenyleneimino)]bis[3-phenyl-1,3-propanedisulfonic
acid] tetrasodium salt; di(γ-phenylpropylamino)-4,4′-diphenylsulfone α,α′,γ,γ′-sodium
tetrasulfonate; tetrasodium 4,4′-bis(γ-phenylpropylamino)diphenylsulfone α,γ,α′,γ′-tetrasulfonate; phenopryldiasulfone sodium; solapsone; RP-3668; Cimedone (Specia); Sulphetrone (Burroughs Wellcome).
C
30H
28N
2Na
4O
14S
5; mol wt 892.83.
C 40.36%, H 3.16%, N 3.14%, Na 10.30%, O 25.09%, S 17.96%.
Description and references
Prepared by reacting 4,4′-diaminodiphenyl sulfone
with more than 2 mols cinnamic aldehyde in the cold and treating the
resulting 4,4′-dicinnamylideneaminodiphenyl sulfone with NaHSO3 soln: Gray, Henry, GB 491265 (1938 to Wellcome Foundation);
Buttle et al., Biochem. J. 32, 1101 (1938). Improved process: Henry, Gray, GB 562216 (1944 to Wellcome Foundation). Properties and estimation: Brownlee et al., Br. J. Pharmacol. 3, 15 (1948).
Properties
Crystals contg 5-7% H2O from alc.
Becomes anhydr at 110° in vacuo. Exceedingly sol in cold
water, giving a neutral soln. 20% and 40% (w/v) aq solns are stable
when neutral or slightly alkaline and may be autoclaved. Practically
insol in cold alc. Solns are incompatible with acids. Absorption
spectrum of dye obtained by diazotization and coupling to N-(1-naphthyl)ethylenediamine hydrochloride: Brownlee, loc. cit.Therapeutic Category
Antibacterial (leprostatic).
Keywords
Antibacterial (Synthetic); Sulfones; Antibacterial (Leprostatic)